Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators

Daniel T. Monaghan, Mark W. Irvine, Blaise Mathias Costa, Guangyu Fang, David E. Jane

Research output: Contribution to journalArticlepeer-review

76 Scopus citations


The NMDA receptor (NMDAR) family of l-glutamate receptors are well known to have diverse roles in CNS function as well as in various neuropathological and psychiatric conditions. Until recently, the types of agents available to pharmacologically regulate NMDAR function have been quite limited in terms of mechanism of action and subtype selectivity. This has changed significantly in the past two years. The purpose of this review is to summarize the many drug classes now available for modulating NMDAR activity. Previously, this included competitive antagonists at the l-glutamate and glycine binding sites, high and low affinity channel blockers, and GluN2B-selective N-terminal domain binding site antagonists. More recently, we and others have identified new classes of NMDAR agents that are either positive or negative allosteric modulators (PAMs and NAMs, respectively). These compounds include the pan potentiator UBP646, the GluN2A-selective potentiator/GluN2C and GluN2D inhibitor UBP512, the GluN2D-selective potentiator UBP551, the GluN2C/GluN2D-selective potentiator CIQ as well as the new NMDAR-NAMs such as the pan-inhibitor UBP618, the GluN2C/GluN2D-selective inhibitor QZN46 and the GluN2A inhibitors UBP608 and TCN201. These new agents do not bind within the l-glutamate or glycine binding sites, the ion channel pore or the N-terminal regulatory domain. Collectively, these new allosteric modulators appear to be acting at multiple novel sites on the NMDAR complex. Importantly, these agents display improved subtype-selectivity and as NMDAR PAMs and NAMs, they represent a new generation of potential NMDAR therapeutics.

Original languageEnglish (US)
Pages (from-to)581-592
Number of pages12
JournalNeurochemistry International
Issue number4
StatePublished - Sep 2012


  • Allosteric modulators
  • Antagonists
  • Channel blockers
  • Competitive inhibitors
  • Glycine
  • NMDA receptors
  • Potentiators

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Cell Biology


Dive into the research topics of 'Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators'. Together they form a unique fingerprint.

Cite this